AstraZeneca Moves Low-Carbon Inhaler Closer to EU Approval
AstraZeneca has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for Trixeo Aerosphere using a next-generation propellant with near-zero Global Warming Potential (GWP). The decision supports the company's plans to reduce the carbon footprint of its respiratory medicines while maintaining treatment for patients with chronic obstructive pulmonary disease (COPD).
Colgate-Palmolive Unveils 2030 Sustainability Strategy to Drive Growth and Impact
Colgate-Palmolive has launched its 2030 Sustainability & Social Impact Strategy, outlining a five-year roadmap focused on delivering measurable environmental and social outcomes while supporting long-term business resilience and growth.
AWS Launches Amazon Bio Discovery to Accelerate AI-Driven Drug Research
AWS has launched Amazon Bio Discovery, a new AI-powered application designed to help life sciences researchers accelerate drug discovery by combining biological foundation models, agentic AI and integrated lab testing workflows.
Philips Drives a Circular Economy Through Sustainable Design
Philips is advancing sustainable innovation across consumer health, leveraging its EcoDesign framework, bio-based materials, refurbishment, and circular solutions to reduce environmental impact whilst meeting growing demand for more responsible, longer-lasting products.
